Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 3:20 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 1,392 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Emergency Room Clear all

Conditions: Genetics of Drug Metabolism
Interventions: Not listed
Lead sponsor: Renaissance RX; Industry
Eligibility: 18 Years and older
Enrollment: 250,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2013
U.S. locations: 49
States / cities: Birmingham, Alabama • Glendale, Arizona • Peoria, Arizona + 39 more

Conditions: Hypertension, Adolescent Behavior, Health Knowledge, Attitudes, Practice
Interventions: Youth-Led Hypertension Education Digital Intervention; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 14 Years and older
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Low Back Pain
Interventions: Ibuprofen, Osteopathic manipulative treatment; Drug · Procedure
Lead sponsor: Albert Einstein Healthcare Network; Other
Eligibility: 18 Years and older
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Sepsis, Systemic Inflammatory Response Syndrome, Infection Mixed, Infection, Bacterial, Infection, Fungal, Infection, Coronavirus, Antibiotic Resistance Genes, Human Genome Analysis
Interventions: Gene Z or other rapid diagnostic techniques developed in our lab (as of 2018 not using Gene Z - now using In-Dx along with other developed techniquesregularly); Device
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2032
U.S. locations: 2
States / cities: Lansing, Michigan

Conditions: Emergency
Interventions: Notification; Other
Lead sponsor: Columbia University; Other
Eligibility: Not listed
Enrollment: 7,023 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Abdominal Pain
Interventions: Ketamine, Morphine; Drug
Lead sponsor: CHRISTUS Health; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Corpus Christi, Texas

Conditions: Head Injury
Interventions: Head CT Decision Aid; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: Up to 18 Years
Enrollment: 971 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 7
States / cities: Sacramento, California • Boston, Massachusetts • Minneapolis, Minnesota + 3 more

Conditions: Migraine
Interventions: Lidocaine, Placebo; Drug
Lead sponsor: New York City Health and Hospitals Corporation; Other
Eligibility: 10 Years to 20 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Alcohol Abuse, Alcohol Dependence
Interventions: Motivational Interview, Assessment; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 2
States / cities: Providence, Rhode Island

Conditions: Pain
Interventions: Fentanyl Nasal Spray, Hydromorphone PCA, Placebo Nasal Spray; Drug · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Asthma
Interventions: Targeted text messages, General text messages; Behavioral
Lead sponsor: Children's Hospitals and Clinics of Minnesota; Other
Eligibility: 4 Years to 17 Years
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Saint Paul, Minnesota

Conditions: Kidney Stones, Ureteral Stones
Interventions: Tamsulosin, Placebo; Drug
Lead sponsor: Robert Swor; Other
Eligibility: 18 Years and older
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Problematic Behavior in Children
Interventions: Not listed
Lead sponsor: New York City Health and Hospitals Corporation; Other
Eligibility: 8 Years to 18 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2020
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Fall, Accidental, Fall, Hospital Readmission, Emergency Medical Services
Interventions: Transport PLUS group; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Delirium
Interventions: Emergency Department Delirium Screening and Detection Program (ED-DDP); Behavioral
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Asthma
Interventions: Nebulized Budesonide, Usual care (albuterol with or without oral steroid); Drug
Lead sponsor: Deborah Gentile; Other
Eligibility: 1 Year to 8 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 2
States / cities: Bellevue, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Health Knowledge, Attitudes, Practice, Sneezing, Constipation, Nasal Congestion and Inflammations
Interventions: Intensified anticipatory guidance, Routine; Behavioral
Lead sponsor: Bronx-Lebanon Hospital Center Health Care System; Other
Eligibility: Female only
Enrollment: 323 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Gastroenteritis
Interventions: LGG, micro-crystalline cellulose; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 3 Months to 48 Months
Enrollment: 971 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 10
States / cities: Sacramento, California • Washington D.C., District of Columbia • Chicago, Illinois + 7 more

Conditions: Asthma, Medical Informatics
Interventions: Paper-based asthma flow diagram; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 2 Years to 18 Years
Enrollment: 1,102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Acute Asthma
Interventions: Tailored asthma management program, Generic web-based education; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 13 Years to 19 Years
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Detroit, Michigan

Conditions: Suicide, Suicidal, Self-Harm
Interventions: SAFETY-A within usual ED Care, Combined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 13 Years to 24 Years
Enrollment: 1,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 5
States / cities: Los Angeles, California • Sylmar, California • Durham, North Carolina + 2 more

Conditions: Evaluation of Video Discharge Instructions in Improving Understanding
Interventions: Standard written discharge instructions, Video Discharge Instructions; Other
Lead sponsor: Augusta University; Other
Eligibility: Not listed
Enrollment: 436 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Asthma
Interventions: pulmicort respules; Drug
Lead sponsor: Phoenix Children's Hospital; Other
Eligibility: 2 Years to 8 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Cellulitis
Interventions: trimethoprim-sulfamethoxazole, Cephalexin; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 12 Months and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 3
States / cities: Boston, Massachusetts

Search by objective public record fields.

Diagnosing Adverse Drug Reactions Registry

Youth-Led Intervention to Improve Blood Pressure

Acute Low Back Pain in the Emergency Department Treated With Osteopathic Manipulative Treatment Versus NSAIDs

Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

Primary-care-provider Identification And Notification

Patient Satisfaction With Subdissociative Dose Ketamine Versus Morphine for Emergency Department Pain Control

Shared Decision Making in Parents of Children With Head Trauma: Head CT Choice

Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department

Enhanced Motivational Interviewing With Alcohol Positive Trauma Patients

Fentanyl for Breakthrough Pain in the Emergency Department

Use of Text Messages to Improve Care For Children Following an ED Visit for Asthma

The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients

Assessment of Bullying in Children

Transport PLUS Intervention

Implementation Outcome Assessments of the Emergency Department Delirium Screening and Detection Program

Effect of Nebulized Budesonide and Oral Corticosteroids on Wheezing Episode Relapse in Children

"Anticipatory Guidance in the Nursery and Its Impact on Non-urgent Emergency Department Visits"

Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis

A Reminder System for Paper-Based Asthma Guidelines in the Pediatric Emergency Department

Feasibility of an ED Initiated Online Asthma Management Program for Urban Teens

Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth

Caregivers' Knowledge of Emergency Department Discharge Instructions Improves With the Use of Video

Pulmicort Respules on Relapse Rates After Treatment in the ED

Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients